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Most high-income countries implement tuberculosis
(TB) infection control programs to reduce the risk for noso-
comial transmission. However, such control programs are
not routinely implemented in India, the country that
accounts for the largest number of TB cases in the world.
Despite the high prevalence of TB in India and the expect-
ed high probability of nosocomial transmission, little is
known about nosocomial and occupational TB there. The
few available studies suggest that nosocomial TB may be a
problem. We review the available data on this topic,
describe factors that may facilitate nosocomial transmis-
sion in Indian healthcare settings, and consider the feasibil-
ity and applicability of various recommended infection
control interventions in these settings. Finally, we outline
the critical information needed to effectively address the
problem of nosocomial transmission of TB in India.
T
he risk that Mycobacterium tuberculosis can be trans-
mitted from patients with active tuberculosis (TB) to
other patients and healthcare workers has been recognized
for many years (1). The level of risk varies by setting,
occupation, patient population, and effectiveness of TB
infection control measures (2–5) but is higher in facilities
that manage large numbers of smear-positive TB patients
who do not receive rapid diagnosis, isolation, and treat-
ment, particularly in the absence of other infection control
measures (2–5). A hierarchy of control measures, includ-
ing administrative, engineering, and environmental con-
trols and personal protection measures, has been
recommended to reduce nosocomial TB risk (2,3,5,6).
These recommended measures are implemented by health-
care facilities in high-income countries (3,6), but given
their high cost, few facilities in low-income countries can
afford to implement them.
The World Health Organization (WHO) has proposed
practical and low-cost interventions to reduce nosocomial
transmission in settings where resources are limited (7).
These recommendations emphasize prompt diagnosis and
rapid treatment of TB rather than expensive technologies,
such as isolation rooms and respirators. However, despite
the widespread implementation of the directly observed
therapy, short course (DOTS) strategy, which is interna-
tionally recommended, compliance with these simpler
guidelines is generally poor in low-income countries (8).
In general, the primary focus of national TB programs
in high-prevalence, low-income countries is to expand
basic DOTS services. Typically, nosocomial transmission
is ignored, given countries’ limited resources, but several
factors illustrate that nosocomial TB must be addressed,
even in such areas. First, nosocomial transmission is of
concern because it affects not only patients who are
exposed but also the healthcare workforce, which could
adversely affect healthcare services over time (7). Second,
transmission of TB can have serious consequences, partic-
ularly with multidrug-resistant TB (MDRTB). Several out-
breaks in the United States demonstrated the role that
hospitals can play as focal points of MDRTB transmission
(9–13), a phenomenon also seen in Europe, South
America, South Africa, and Russia (14–16). These out-
breaks can be explosive and associated with high death
rates because hospitalized patients are often immunocom-
promised (2,9). Therefore, interventions to reduce nosoco-
mial transmission of TB are useful and cost-effective
preventive measures to control TB, including MDRTB,
particularly in tertiary care settings.
Third, nosocomial TB must be addressed because it can
help the healthcare system, particularly the private health
sector, improve TB diagnosis and treatment and better
align practices with the DOTS strategy. For example,
detecting smear-positive TB with microscopy is a key
component of the DOTS strategy and an important admin-
istrative infection control measure. However, several stud-
ies have shown that private practitioners in India tend
to underutilize microscopy and rely more on chest
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tion of infection control measures might motivate the pri-
vate healthcare sector to adopt the DOTS strategy, and
implementation of the DOTS strategy may, in turn,
enhance infection control.
Fourth, even though low-income countries have fewer
resources, ignoring a potential hazard runs contrary to the
principles of protecting human health, the cornerstone of
health care in any country. Finally, the problem of control-
ling TB in hospitals is not a problem with TB alone but
reflects a problem with infection control in general, which,
if improved, could also prevent other infectious diseases
(e.g., severe acute respiratory syndrome and avian influen-
za) that may be nosocomially transmitted. Thus, TB infec-
tion control programs can have secondary benefits.
Ultimately, preventing outbreaks and protecting patients
and staff are in the interests of healthcare facilities. TB
infection control is a good starting point for such efforts.
In this article, we focus on India as a case study and
review available studies on nosocomial TB, describe fac-
tors that facilitate nosocomial transmission, and consider
the feasibility of various recommended TB infection con-
trol interventions. Finally, we outline critical questions that
need to be studied to effectively address nosocomial TB.
Although we focus on India, the issues we raise may be
applicable to other high-prevalence, resource-limited
countries.
Nosocomial TB in India
India has more TB patients than any other country (20)
and accounts for one fifth of the world’s incident TB cases
(21); the reported incidence in 2003 was 168 per 100,000
(20). Every year, TB develops in nearly 2 million persons
in India, and nearly 1 million cases are smear positive; an
estimated 40% of the Indian population is latently infected
with  M. tuberculosis (21). India’s Revised National TB
Control Programme (RNTCP) now provides access to
DOTS for >85% of the population (21). Countrywide cov-
erage is anticipated in 2006 (22). This program is the fastest
expanding DOTS program in the world and the largest in
the world in terms of patients receiving initial treatment
(21). Outside of the RNTCP, India has a large private health
sector that is actively involved in providing TB care
(23,24); almost half of patients with TB in India initially
seek care from the private sector (22). Thus, because Indian
healthcare workers see large numbers of TB patients and
because large numbers of TB patients are hospitalized (25),
the risk for nosocomial exposure is substantial.
Despite the prevalence of TB in India and the expected
high probability of nosocomial transmission, little is
known about nosocomial TB. In fact, until 2004, no stud-
ies on nosocomial TB in India had been published. Table 1
summarizes the results of recent studies on TB among
healthcare workers from 3 large tertiary hospitals (26–30).
These studies provide some data on the incidence of active
TB (28,29), prevalence of latent TB infection (26), risk
factors for active TB (30), and annual risk for latent TB
infection among healthcare workers (27). In addition,
another recent study documented person-to-person trans-
mission of TB among hospitalized patients (31).
At a rural medical school hospital in Sevagram, Pai et
al. performed the tuberculin skin test (TST) and a whole-
blood interferon-γ release assay (IGRA) for 726 healthcare
workers (26); 50% were positive by either TST or IGRA.
Nearly 70% of the participants reported direct contact with
sputum smear–positive TB patients. Exposure was partic-
ularly high among physicians in training, attending physi-
cians, and nurses. Increasing age and duration of
employment were risk factors for latent TB infection.
Nurses, nursing students, orderlies, and laboratory staff
had higher prevalence of latent infection (26). Arepeat sur-
vey of 216 medical and nursing students in this cohort
enabled estimation of the annual risk for latent infection by
using TST and IGRA (27). When both tests were used, the
annual risk for latent TB infection was estimated to be 5%
(27). The estimated community-based annual risk for
infection in India is 1.5% (32), so the excess risk of 3.5%
may be attributable to nosocomial exposure.
At a tertiary care hospital in Chandigarh, Rao et al. esti-
mated the incidence of active TB among resident physi-
cians (28). Among residents already working in the
hospital, TB developed in 9 (2%) of 470, for an incidence
of 11.2 new cases per 1,000 person-years of exposure.
Extrapulmonary disease developed in two thirds of the res-
idents. Overall, this study showed a high rate of TB (pre-
dominantly extrapulmonary) among those who worked in
medical subspecialties. However, most cases were identi-
fied by using clinical criteria, and few were bacteriologi-
cally confirmed.
In a retrospective review of healthcare workers who
underwent anti-TB treatment in a tertiary care hospital in
Vellore, Gopinath et al. identified 125 healthcare workers
who had been treated for active TB between 1992 and
2001 (29). The annual incidence of pulmonary TB was
0.35–1.80 per 1,000 persons during this period. The annu-
al incidence of extrapulmonary TB was 0.34–1.57 per
1,000. These rates may have been underestimated because
only healthcare workers who underwent TB treatment
were counted. In this hospital, a case-control study showed
that low body mass index and employment in medical
wards were risk factors for TB disease among healthcare
workers (30).
In a molecular epidemiologic study at a TB hospital in
Delhi, Bhanu et al. performed DNA fingerprinting on 83
M. tuberculosis isolates from patients in 2 adjacent wards
(31). Of these 83 isolates, 8 strains were grouped into
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tion fragment length polymorphism and spoligotyping
analyses. Within each cluster, epidemiologic data showed
overlapping hospitalization periods, which raises the pos-
sibility of nosocomial transmission (31).
In summary, these studies suggest that nosocomial
transmission of TB is a problem in India. The prevalence
of latent TB infection and annual risk for TB infection
appears to be high even among young healthcare workers.
For example, in a hypothetical Indian hospital with 1,000
workers, ≈500 (50%) will likely have latent infection, and
≈25 (5%) of uninfected workers will be newly infected
each year. The rate of active disease appears to be exceed-
ingly high in subgroups such as interns, residents, and
nurses. The incidences of TB disease and infection are
higher than the national averages, which suggests an
increased risk for acquiring TB in the hospital setting. For
example, the estimated incidence of TB among residents
was 10-fold higher than the incidence for the country (28).
The predominance of extrapulmonary (mostly pleural)
disease among healthcare workers may indicate progres-
sion to disease from newly acquired primary infection
rather than reactivation of latent TB. Molecular epidemio-
logic studies suggest that pleural TB is different from other
forms of extrapulmonary TB and is associated with the
highest fingerprint clustering rate of all forms of TB, which
suggests that pleural TB may be an early manifestation of
recent infection (33). Lastly, although this assumption is
based on limited data, nosocomial transmission of TB
among hospitalized patients may occur in urban hospitals.
Factors That May Facilitate Nosocomial
Transmission
Several factors may facilitate nosocomial transmission
in Indian hospitals, although their relative importance in
facilitating transmission is unknown (Table 2). The over-
whelming number of TB patients and repeated exposures
to smear-positive TB patients are likely to be critical fac-
tors. The RNTCP alone starts treatment for >100,000
patients every month (21), and thousands more are man-
aged in the private sector (19,22–24). Repeated exposure
of trainees is particularly worrisome, given the lack of TB
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India, students begin the undergraduate medical program
at the age of 17 or 18 years. After an initial classroom-
based program in basic sciences, they begin their clinical
rotations during years 2 and 3. During this phase of their
training, stress is placed on physical examination.
Evaluation of the respiratory system, for example, is
invariably included in licensure examinations. Because
patients with cavitary TB are likely to exhibit signs during
a lung exam, TB patients are considered excellent teaching
material. Trainees spend considerable time eliciting physi-
cal signs in such patients, which results in repeated expo-
sure to patients with infectious TB during trainees’ first
clinical rotations. This fact may explain the high incidence
of infection among them (27).
Delays in diagnosis and initiation of treatment and fail-
ure to separate or isolate patients with smear-positive TB
from other patients also contribute to transmission risk.
Previous studies in India have shown that diagnostic
delays are common, and private practitioners, in particular,
tend to underuse sputum microscopy, thereby increasing
the probability of missing infectious TB patients
(17,19,34). Unnecessary or prolonged hospitalization of
TB patients who could have been treated on an ambulato-
ry basis might also contribute to high exposure levels in
hospitals. A survey of TB hospitals in India showed that
nearly 1 million patients sought treatment in 1999.
Approximately 77% of these patients were reported to
have undergone sputum examination, and one third of all
patients had a diagnosis of TB (25). Approximately one
third of the hospitals admitted every sputum smear–posi-
tive TB patient encountered at their institution.
Several factors might prolong infectiousness of TB
patients and thereby facilitate nosocomial transmission.
Poor adherence to treatment, lack of continuous drug sup-
ply, use of suboptimal treatment regimens, lack of ade-
quate treatment support (e.g., direct observation of therapy
[DOT]), and insufficient treatment duration have been
reported, particularly in the private sector (18,19,24,25,
35,36).
Few hospitals in India have established infection con-
trol procedures. Hospitals, especially publicly owned facil-
ities, tend to be crowded, poorly ventilated, and have
limited or no facilities for respiratory isolation. Most res-
piratory care procedures (including sputum collection) are
routinely carried out in a general ward setting, rather than
in respiratory isolation rooms. Further, few of these hospi-
tals offer routine screening programs to detect and treat TB
among healthcare workers.
Previous surveys have identified gaps in knowledge
and awareness about TB in healthcare workers in India
(18,19,24,36,37). A survey of 213 nurses in 2 hospitals in
Delhi showed that only 67% reported M. tuberculosis as
the causative organism, and only 22% reported sputum
microscopy as the most appropriate way to diagnose TB
(37). In another survey, only 12% of 204 private practition-
ers in Delhi reported ordering sputum smears for a patient
with suspected TB. For treating TB, 187 physicians used
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similar findings in India (17,19,24,35,36). Finally, health-
care workers may believe that that they cannot avoid noso-
comial infection, which results in resigned acceptance on
their part. Since nearly half the Indian population is infect-
ed, healthcare workers do not view latent TB infection as
a problem. Hence, latent infection is rarely treated, even in
high-risk groups such as household contacts and HIV-
infected patients (38,39).
Implementing TB Infection Control in India
Effective TB infection control in healthcare settings
depends on early identification, isolating infected persons,
and rapidly and effectively treating persons with TB
(2,4,5). In all healthcare settings, a basic TB infection con-
trol program should be implemented, as recommended by
WHO and other agencies (2–5,7). WHO also recommends
developing an infection control plan, educating healthcare
workers and patients, improving sputum collection prac-
tices, performing triage and evaluation of suspected TB
patients in outpatient settings, and reducing exposure in
the laboratory (7). In the United States, administrative con-
trols (early detection, isolation, and treatment of patients
with TB) have been the most effective components of TB
infection control programs (9).
In India, of all the recommended interventions, imple-
menting administrative controls is likely to be the most
feasible and effective strategy. Controls include early
detection of patients with infectious TB, isolating or at
least segregating those with infectious pulmonary TB from
other patients, and rapidly initiating anti-TB treatment,
supported by measures to improve adherence (e.g., DOT).
Implementing many of the recommended engineering
controls is not feasible in most healthcare facilities because
of the high costs of such measures (e.g., negative-pressure
isolation rooms). However, separation or segregation of
smear-positive TB patients in private or semiprivate rooms
or wards with simple mechanical exhaust ventilation (e.g.,
window fans) could be feasible in some settings, particu-
larly in the private sector and well-funded public hospitals.
These measures have been shown to be useful in terminat-
ing an outbreak of nosocomial tuberculosis (9). This inter-
vention is particularly necessary at centers that manage
patients with MDRTB; at such centers, patients with infec-
tious TB must not be admitted to the same wards as
patients with HIV infection.
Personal respiratory protection measures (e.g., N95 res-
pirators) are probably not feasible because of the high cost.
Respirators may be relatively costly to implement and of
limited effectiveness in high-incidence, resource-limited
settings. (40). The use of respirators may have a role in
hospitals that manage MDRTB, but more successful and
affordable measures include improving natural ventilation
through open windows and sunlight. The efficacy of UV
germicidal lights is being evaluated in other low-income
countries, and results of such studies are needed to deter-
mine their value in reducing nosocomial transmission. In
developing TB infection control programs, crucial issues
are educating healthcare workers about nosocomial TB
and measures that can help prevent such transmission, edu-
cating patients on cough procedures, and using simple sur-
gical masks on patients with infectious TB (especially if
they are not segregated) who are coughing.
Periodic testing of healthcare workers for latent TB and
treating those with latent infections who are at high risk for
progression to active TB might be feasible in selected set-
tings, particularly among trainees and junior staff (who
seem to be disproportionately affected). Screening for
latent TB infection with newer, blood-based IGRAs may
not be feasible in most settings at this time. Although
IGRAs have some advantages over TST, including
increased specificity and the ability to discriminate
between infection with M. tuberculosis and M. bovis BCG,
they have limited applicability in many resource-limited
settings because of the high costs and the need for labora-
tory infrastructure (26,41). However, new data suggest that
IGRAs hold promise for serial testing of healthcare work-
ers and can overcome some of the limitations of serial
tuberculin testing (27). A recent study from India showed
that in a setting with intensive nosocomial exposure,
healthcare workers had strong interferon-γ responses that
persistently stayed elevated even after treatment for latent
infection (42). Persistence of infection or reexposure might
account for this phenomenon.
Evaluation of symptomatic healthcare workers for
active TB is feasible and should be implemented routinely.
In addition to the above measures, hospitals should make
every effort to treat TB patients on an ambulatory basis
(25). If hospitalization is required, every effort should be
made to segregate potentially infectious patients from
immunocompromised patients, rapidly diagnose and initi-
ate treatment, and discharge patients promptly with DOT
on an outpatient basis.
Lastly, efforts should be made to improve the quality of
TB care in the private sector through better coordination
between the RNTCP and the private sector (22). By
improving TB diagnosis and treatment practices, smear-
positive TB patients are more likely to receive rapid diag-
nosis and treatment, thereby directly and indirectly
reducing the overall transmission in the community and in
the nosocomial setting. Such public-private partnerships
are currently ongoing in India (22), and these programs
could address the issue of nosocomial TB.
Who should design and implement TB infection control
programs in India? This is a complicated issue because of
the variability of healthcare systems in India (e.g., public,
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ical systems). Further, the private sector in India is domi-
nant, diverse, and largely unregulated (22). Although a few
hospitals have received quality certifications (e.g., ISO
9000), no pressure is on healthcare facilities to get accred-
ited; in fact, India has no national accrediting body. Also,
a large proportion of Indians pay for health care with per-
sonal funds rather than health insurance.
Given these problems, we cannot envision a simple
approach to implementing infection control programs in
India. While technical guidance should come from interna-
tional agencies such as WHO and the International Union
Against Tuberculosis and Lung Disease, these guidelines
need to be adapted to the Indian context by RNTCP.
Ultimately, implementing adequate infection control meas-
ures is the responsibility of each healthcare facility.
RNTCP may not have the regulatory authority to enforce
implementation; however, by partnering with the private
sector, RNTCP can improve the quality of case detection
and treatment provided in the private sector, which can, by
itself, improve infection control.
Call for Research and Action
Despite India’s long and distinguished history of TB
research, nosocomial TB has in large part not been
addressed by researchers, at least until recently. Although
a few studies have been published (26–31), many more
are needed, as summarized in Table 3. A first step is to
determine the prevalence of TB among healthcare work-
ers and to evaluate risk factors for nosocomial transmis-
sion. In addition, we must assess the availability of
resources in India to implement TB infection control
measures and to assess what additional resources are
needed in areas that have little or no TB infection control
programs. India is a vast country with substantial region-
al variability in resources and expertise. Some healthcare
facilities (e.g., private hospitals and medical schools) may
have implemented control measures or may have the
resources and skills needed to establish effective infection
control programs.
After assessing the disease prevalence, risk factors, and
resources, India must implement effective strategies to
reduce nosocomial transmission. To intervene, we will
need to know what interventions will and will not work in
India. Trials are therefore needed to evaluate relatively
simple, feasible interventions and their effectiveness in
reducing nosocomial risk. The lessons learned in such tri-
als will be applicable in other resource-limited settings.
In conclusion, healthcare workers are essential in the
fight against TB, and their health needs to be protected.
India, with its vast human and intellectual capital, nearly
countrywide DOTS coverage, and a large, well-funded,
successful national TB control program, is well placed to
tackle this problem and set an example for other high-
prevalence countries.
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